scholarly journals Does intravenous lidocaine added to nonsteroidal anti-inflammatory drugs reduce pain during colposcopy? A prospective randomized double-blind study

2021 ◽  
Author(s):  
Yunus Emre Topdaği ◽  
Emsal Pinar Topdagi Yilmaz ◽  
Muhammed Enes Aydin ◽  
Irem Ates ◽  
Elif Oral Ahiskalioglu
Keyword(s):  
Blind Study ◽  
Double Blind Study ◽  
Intravenous Lidocaine ◽  
Double Blind ◽  
Inflammatory Drugs ◽  
Anti Inflammatory

Postoperative analgesic efficacy of perioperative intravenous lidocaine infusion in patients undergoing septorhinoplasty: a prospective, randomized, double-blind study

2020 ◽  
Vol 277 (4) ◽  
pp. 1095-1100 ◽  
Author(s):  
İrem Ates ◽  
Muhammed Enes Aydin ◽  
Ali Ahiskalioglu ◽  
Elif Oral Ahiskalioglu ◽  
Zulkuf Kaya ◽  
...  
Keyword(s):  
Analgesic Efficacy ◽  
Blind Study ◽  
Double Blind Study ◽  
Intravenous Lidocaine ◽  
Double Blind

Intravenous lidocaine vs. NSAIDs for migraine attack in the ED: a prospective, randomized, double-blind study

2021 ◽  
Author(s):  
Sultan Tuna Akgol Gur ◽  
Elif Oral Ahiskalioglu ◽  
Muhammed Enes Aydin ◽  
Abdullah Osman Kocak ◽  
Pelin Aydin ◽  
...  
Keyword(s):  
Migraine Attack ◽  
Blind Study ◽  
Double Blind Study ◽  
Intravenous Lidocaine ◽  
Double Blind

A Double-Blind Study of Ibuprofen Versus Placebo in the Treatment of Acute Migraine Attacks

Cephalalgia ◽  
1992 ◽  
Vol 12 (3) ◽  
pp. 169-171 ◽  
Author(s):  
Reidar Kloster ◽  
Knut Nestvold ◽  
Steinar T Vilming
Keyword(s):  
Side Effects ◽  
Initial Dose ◽  
Acute Treatment ◽  
Blind Study ◽  
Double Blind Study ◽  
Acute Migraine ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Inflammatory Drug ◽  
Anti Inflammatory

The efficacy of ibuprofen, a non-steroidal anti-inflammatory drug, was assessed in the acute treatment of migraine. Twenty-five patients completed a double-blind placebo-controlled multicrossover trial. The initial dose of ibuprofen was 1200 mg. Six migraine attacks were randomly treated in each patient, three with ibuprofen and three with placebo. The results indicated a statistically significant reduction in the duration of the migraine attacks and also a statistically significant reduction in the severity of headache and nausea in the ibuprofen-treated attacks. The use of additional medication was significantly reduced in the ibuprofen-treated attacks (25.6% vs 57.5%), No serious side effects were reported. Ibuprofen is valuable in the treatment of acute migraine attacks.

Sign in / Sign up

Export Citation Format

Share Document